Noncentral nervous system systemic embolism in patients with atrial fibrillation: Results From ROCKET AF (rivaroxaban once daily, oral, direct factor xa inhibition compared with Vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation)

Ryan Orgel, Daniel Wojdyla, David Huberman, Jonathan L. Halperin, Günter Breithardt, Daniel E. Singer, Keith A.A. Fox, Graeme J. Hankey, Kenneth W. Mahaffey, W. Schuyler Jones, Manesh R. Patel

Research output: Contribution to journalArticlepeer-review

7 Scopus citations
Original languageEnglish
Article numbere003520
JournalCirculation: Cardiovascular Quality and Outcomes
Issue number5
StatePublished - 1 May 2017

Cite this